Skip to content
Catalyst

PapersPMID:41208045

Association of preoperative metformin use with postoperative mortality and morbidity in type 2 diabetes patients undergoing noncardiac surgery: a retrospective cohort study.

Korean journal of anesthesiology2026The record ↗

  1. Finding, moderate evidencelowersAll-cause mortality

What moved

1 findingHow to read these marks →
  • “Before weighting, the 30-day and five-year mortalities after surgery were lower in the metformin group than in the non-metformin group (0.3% vs. 1.0%; P < 0.001 for 30-day mortality and 13.6% vs. 19.7%; P < 0.001 for five-year mortality).”
    Study
    cohort
    Population
    adults with type 2 diabetes undergoing noncardiac surgery, metformin users vs non-users; secondary endpoint, unadjusted (before IPTW weighting), five-year follow-up horizon

Study record

Design
cohort study
Species
human
Population
Adult patients with type 2 diabetes mellitus using antidiabetic agents at hospital admission, undergoing noncardiac surgery 2011-2019 at Samsung Medical Center, Seoul, Korea
Participants
22,944
Comparator
observational
Duration
2,995 days
Endpoints measured
12